Effect of vascular endothelial growth factor upregulation on retinal gene expression in the Kimba mouse

Clinical and Experimental Ophthalmology

Volumn 41, Issue 3, 2013, Pages 251-262

  Binz, Nicolette ^a,b   Ali Rahman, Ireni S ^b   Chinnery, Holly R ^b,c   McKeone, Richard ^a,b   Simpson, Ken M ^d   Speed, Terence P ^d   Lai, Chooi May ^b   Rakoczy, P Elizabeth ^b  

^a LIONS EYE INSTITUTE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Diabetic retinopathy; Kimba; Neovascularization; Retinal architecture; TrVEGF029.

Indexed keywords

BETACELLULIN; CELL NUCLEUS RECEPTOR; ENDOTHELIN 2; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GLIAL FIBRILLARY ACIDIC PROTEIN; MESSENGER RNA; NUCLEAR RECEPTOR NR2E3; SEMAPHORIN; SEMAPHORIN 3C; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROARRAY ANALYSIS; MOUSE; MUELLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOTORECEPTOR CELL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETINA; RETINA NEOVASCULARIZATION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; DIABETIC RETINOPATHY; ENDOTHELIN-2; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, TRANSGENIC; ORPHAN NUCLEAR RECEPTORS; REAL-TIME POLYMERASE CHAIN REACTION; RETINAL NEOVASCULARIZATION; SEMAPHORINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84876316567     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2012.02845.x     Document Type: Article

References (41)

1. Barber AJ. A new view of diabetic retinopathy: a neurodegenerative disease of the eye. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 283-90.
2. Feit-Leichman RA, Kinouchi R, Takeda M etal. Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 2005; 46: 4281-7.
3. Lieth E, Gardner TW, Barber AJ, Antonetti DA. Retinal neurodegeneration: early pathology in diabetes. Clin Experiment Ophthalmol 2000; 28: 3-8.
4. van Dijk HW, Kok PH, Garvin M etal. Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy. Invest Ophthalmol Vis Sci 2009; 50: 3404-9.
5. Campochiaro PA. Retinal and choroidal neovascularization. J Cell Physiol 2000; 184: 301-10.
6. Lai CM, Dunlop SA, May LA etal. Generation of transgenic mice with mild and severe retinal neovascularisation. Br J Ophthalmol 2005; 89: 911-16.
7. Okamoto N, Tobe T, Hackett SF etal. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization. Am J Pathol 1997; 151: 281-91.
8. Rakoczy EP, Ali Rahman IS, Binz N etal. Characterization of a mouse model of hyperglycemia and retinal neovascularisation. Am J Pathol 2010; 177: 2659-70.
9. Shen WY, Lai CM, Graham CE etal. Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model. Diabetologia 2006; 49: 1690-701.
10. Tee LB, Penrose MA, O'Shea JE, Lai CM, Rakoczy EP, Dunlop SA. VEGF-induced choroidal damage in a murine model of retinal neovascularisation. Br J Ophthalmol 2008; 92: 832-8.
11. van Eeden PE, Tee LB, Lukehurst S etal. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization. Invest Ophthalmol Vis Sci 2006; 47: 4638-45.
12. D'Amore PA. Vascular endothelial cell growth factor-a: not just for endothelial cells anymore. Am J Pathol 2007; 171: 14-18.
13. Nishijima K, Ng YS, Zhong L etal. Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 2007; 171: 53-67.
14. Robinson GS, Ju M, Shih SC etal. Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development. FASEB J 2001; 15: 1215-17.
15. Saint-Geniez M, Maharaj AS, Walshe TE etal. Endogenous VEGF is required for visual function: evidence for a survival role on muller cells and photoreceptors. Plos ONE 2008; 3: e3554.
16. Ali Rahman IS, Li CR, Lai CM, Rakoczy EP. In vivo monitoring of VEGF-induced retinal damage in the Kimba mouse model of retinal neovascularization. Curr Eye Res 2011; 36: 654-62.
17. Binz N, Graham CE, Simpson K etal. Long-term effect of therapeutic laser photocoagulation on gene expression in the eye. FASEB J 2006; 20: 383-5.
18. Irizarry RA, Hobbs B, Collin F etal. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-64.
19. Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry RA, Huber W, eds. Limma: Linear Models for Microarray Data. New York: Springer, 2005; 397-420.
20. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 365-86.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 2001; 25: 402-8.
22. Webber AL, Hodor P, Thut CJ etal. Dual role of Nr2e3 in photoreceptor development and maintenance. Exp Eye Res 2008; 87: 35-48.
23. Joly S, Lange C, Thiersch M, Samardzija M, Grimm C. Leukemia inhibitory factor extends the lifespan of injured photoreceptors in vivo. J Neurosci 2008; 28: 13765-74.
24. Kholodnyuk ID, Kozireva S, Kost-Alimova M, Kashuba V, Klein G, Imreh S. Down regulation of 3p genes, LTF, SLC38A3 and DRR1, upon growth of human chromosome 3-mouse fibrosarcoma hybrids in severe combined immunodeficiency mice. Int J Cancer 2006; 119: 99-107.
25. Kim HS, Shin HS, Kwak HJ, Cho CH, Lee CO, Koh GY. Betacellulin induces angiogenesis through activation of mitogen-activated protein kinase and phosphatidylinositol 3′-kinase in endothelial cell. FASEB J 2003; 17: 318-20.
26. Rattner A, Nathans J. The genomic response to retinal disease and injury: evidence for endothelin signaling from photoreceptors to glia. J Neurosci 2005; 25: 4540-9.
27. Reeves CV, Dufraine J, Young JA, Kitajewski J. Anthrax toxin receptor 2 is expressed in murine and tumor vasculature and functions in endothelial proliferation and morphogenesis. Oncogene 2010; 29: 789-801.
28. Sanderson MP, Erickson SN, Gough PJ etal. ADAM10 mediates ectodomain shedding of the betacellulin precursor activated by p-aminophenylmercuric acetate and extracellular calcium influx. J Biol Chem 2005; 280: 1826-37.
29. May LA, Lai CM, Rakoczy PE. In vitro comparison studies of truncated rhodopsin promoter fragments from various species in human cell lines. Clin Experiment Ophthalmol 2003; 31: 445-50.
30. Akhmedov NB, Piriev NI, Chang B etal. A deletion in a photoreceptor-specific nuclear receptor mRNA causes retinal degeneration in the rd7 mouse. Proc Natl Acad Sci U S A 2000; 97: 5551-6.
31. Cheng H, Khanna H, Oh EC, Hicks D, Mitton KP, Swaroop A. Photoreceptor-specific nuclear receptor NR2E3 functions as a transcriptional activator in rod photoreceptors. Hum Mol Genet 2004; 13: 1563-75.
32. Haider NB, Mollema N, Gaule M etal. Nr2e3-directed transcriptional regulation of genes involved in photoreceptor development and cell-type specific phototransduction. Exp Eye Res 2009; 89: 365-72.
33. Kobayashi M, Takezawa S, Hara K etal. Identification of a photoreceptor cell-specific nuclear receptor. Proc Natl Acad Sci U S A 1999; 96: 4814-19.
34. Haider NB, Naggert JK, Nishina PM. Excess cone cell proliferation due to lack of a functional NR2E3 causes retinal dysplasia and degeneration in rd7/rd7 mice. Hum Mol Genet 2001; 10: 1619-26.
35. Bastian SE, Dunbar AJ, Priebe IK, Owens PC, Goddard C. Measurement of betacellulin levels in bovine serum, colostrum and milk. J Endocrinol 2001; 168: 203-12.
36. Donners MM, Wolfs IM, Olieslagers S etal. A disintegrin and metalloprotease 10 is a novel mediator of vascular endothelial growth factor-induced endothelial cell function in angiogenesis and is associated with atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30: 2188-95.
37. Bringmann A, Reichenbach A. Role of Muller cells in retinal degenerations. Front Biosci 2001; 6: E72-92.
38. Garcia M, Vecino E. Role of Muller glia in neuroprotection and regeneration in the retina. Histol Histopathol 2003; 18: 1205-18.
39. Di Polo A, Aigner LJ, Dunn RJ, Bray GM, Aguayo AJ. Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells. Proc Natl Acad Sci U S A 1998; 95: 3978-83.
40. Isenmann S, Klocker N, Gravel C, Bahr M. Short communication: protection of axotomized retinal ganglion cells by adenovirally delivered BDNF in vivo. Eur J Neurosci 1998; 10: 2751-6.
41. Sakamoto T, Ueno H, Goto Y, Oshima Y, Ishibashi T, Inomata H. A vitrectomy improves the transfection efficiency of adenoviral vector-mediated gene transfer to Muller cells. Gene Ther 1998; 5: 1088-97.